Literature DB >> 11223326

Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40.

J G van Manen1, P J Bindels, C J IJzermans, J S van der Zee, B J Bottema, E Schadé.   

Abstract

The goal of this study is to determine the prevalence of 23 common diseases in subjects with a chronic airway obstruction and in controls. All subjects with a known diagnosis by their general practitioner of asthma or chronic obstructive pulmonary disease (COPD), and who were 40 years and older were selected (n = 1145). Subjects who were willing to participate (n = 591) and who appeared to have an irreversible airway obstruction (n = 290) were included. To recruit controls, a random sample was taken of 676 individuals who were 40 years and older and who were not diagnosed as having asthma or COPD by their general practitioner. Of these 676 individuals 421 were willing to participate. The presence of diseases was determined by using a questionnaire. One hundred and ninety-four subjects (73%) and 229 controls (63%) were shown to be suffering from one or more (other) diseases. In both groups, locomotive diseases, high blood pressure, insomnia and heart disease were most common. Locomotive diseases, insomnia, sinusitis, migraine, depression, stomach or duodenal ulcers and cancer were significantly more common in the subject group than in the control group. For both clinical and research purposes, it is important to consider the presence of diseases in patients with a chronic airway obstruction.

Entities:  

Mesh:

Year:  2001        PMID: 11223326     DOI: 10.1016/s0895-4356(01)00346-8

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  41 in total

1.  Therapies for insomnia and comorbid chronic obstructive pulmonary disease with a focus on ramelteon (rozerem).

Authors:  Jack Greenberg; J B Goss
Journal:  P T       Date:  2009-09

2.  An Official American Thoracic Society Workshop Report: Evaluation and Management of Asthma in the Elderly.

Authors:  Gwen S Skloot; Paula J Busse; Sidney S Braman; Elizabeth J Kovacs; Anne E Dixon; Carlos A Vaz Fragoso; Nicola Scichilone; Y S Prakash; Christina M Pabelick; Sameer K Mathur; Nicola A Hanania; Wendy C Moore; Peter G Gibson; Susan Zieman; Betina B Ragless
Journal:  Ann Am Thorac Soc       Date:  2016-11

3.  The added effect of comorbidity on health-related quality of life in patients with asthma.

Authors:  Wenjia Chen; Larry D Lynd; J Mark FitzGerald; Carlo A Marra; Roxanne Rousseau; Mohsen Sadatsafavi
Journal:  Qual Life Res       Date:  2015-06-03       Impact factor: 4.147

Review 4.  Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.

Authors:  Edwin J Wagena; Maurice P A Zeegers; Constant P van Schayck; Emiel F M Wouters
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 5.  Ageing and the epidemiology of multimorbidity.

Authors:  Miguel J Divo; Carlos H Martinez; David M Mannino
Journal:  Eur Respir J       Date:  2014-08-19       Impact factor: 16.671

6.  Psychological distress and depressed mood in employees with asthma, chronic bronchitis or emphysema: a population-based observational study on prevalence and the relationship with smoking cigarettes.

Authors:  Edwin J Wagena; Ijmert Kant; Marcus J H Huibers; Ludovic G P M van Amelsvoort; Gerard M H Swaen; Emiel F M Wouters; Constant P van Schayck
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 7.  Comorbidities in chronic obstructive pulmonary disease.

Authors:  Wissam M Chatila; Byron M Thomashow; Omar A Minai; Gerard J Criner; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

8.  Co-morbidity and acute decompensations of COPD requiring non-invasive positive-pressure ventilation.

Authors:  Raffaele Scala; Sandra Bartolucci; Mario Naldi; Marcello Rossi; Mark W Elliott
Journal:  Intensive Care Med       Date:  2004-07-17       Impact factor: 17.440

9.  The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings.

Authors:  Javier de Miguel-Díez; Pilar Carrasco-Garrido; Javier Rejas-Gutierrez; Antonio Martín-Centeno; Elena Gobartt-Vázquez; Valentín Hernandez-Barrera; Angel Gil de Miguel; Rodrigo Jimenez-Garcia
Journal:  BMC Cardiovasc Disord       Date:  2010-02-18       Impact factor: 2.298

10.  Asthma and chronic obstructive pulmonary disease: differences between workers with and without sick leave.

Authors:  C R L Boot; J W J van der Gulden; K H Orbon; J H M M Vercoulen; R Akkermans; C van Weel; H T M Folgering
Journal:  Int Arch Occup Environ Health       Date:  2004-04-24       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.